SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 55.13 |
| Enterprise Value ($M) | 44.28 |
| Book Value ($M) | -271.80 |
| Book Value / Share | -11.59 |
| Price / Book | -0.20 |
| NCAV ($M) | -460.13 |
| NCAV / Share | -19.61 |
| Price / NCAV | -0.12 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | n/a |
| Return on Assets (ROA) | -0.70 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 0.19 |
| Current Ratio | 0.19 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 50.15 |
| Assets | 238.48 |
| Liabilities | 510.29 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Earnings Per Share Basic And Diluted | n/a |
| Earnings Per Share Diluted | n/a |
| Earnings Per Share Basic | n/a |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Deep Track Capital, LP | 0.00 | -100.00 | |
| 13G/A | Point72 Asset Management, L.P. | 0.10 | -99.92 | |
| 13G | BlackRock, Inc. | 7.30 | 0.00 | |
| 13G/A | Vanguard Group Inc | 10.24 | -92.90 | |
| 13G/A | Artal International S.C.A. | 4.10 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 83,283 | 269,960 | 30.85 | |
| 73,195 | 279,856 | 26.15 | |
| 146,149 | 480,531 | 30.41 | |
| 64,330 | 272,716 | 23.59 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ADIL – Adial Pharmaceuticals, Inc. | ADTX – Aditxt, Inc. |
| ADVM – Adverum Biotechnologies, Inc. | AIMD – Ainos, Inc. |
| AKAN – Akanda Corp. |